These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33000270)

  • 1. [Corrigendum] MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in vitro.
    Ji CX; Fan YH; Xu F; Lv SG; Ye MH; Wu MJ; Zh XG; Wu L
    Oncol Rep; 2020 Nov; 44(5):2317-2318. PubMed ID: 33000270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retracted] MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in vitro.
    Ji CX; Fan YH; Xu F; Lv SG; Ye MH; Wu MJ; Zhu XG; Wu L
    Oncol Rep; 2020 Dec; 44(6):2792. PubMed ID: 33125093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Corrigendum] Ski prevents TGF‑β‑induced EMT and cell invasion by repressing SMAD‑dependent signaling in non‑small cell lung cancer.
    Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
    Oncol Rep; 2021 Feb; 45(2):787-788. PubMed ID: 33416110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT‑related genes Snail and E‑cadherin.
    Qiu Y; Liu Y; Li WH; Zhang HQ; Tian XX; Fang WG
    Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 38963043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.
    Cai C; He H; Duan X; Wu W; Mai Z; Zhang T; Fan J; Deng T; Zhong W; Liu Y; Zhong W; Zeng G
    Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corrigendum] Induction of microRNA‑let‑7a inhibits lung adeno-carcinoma cell growth by regulating cyclin D1.
    Zhao W; Hu JX; Hao RM; Zhang Q; Guo JQ; Li YJ; Xie N; Liu LY; Wang PY; Zhang C; Xie SY
    Oncol Rep; 2024 May; 51(5):. PubMed ID: 38456515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of epithelial‑to‑mesenchymal transition via suppressing the ROS/ERK/Slug/E‑cadherin pathway.
    Zhao Z; Sun YS; Chen W; Lv LX; Li YQ
    Oncol Rep; 2024 Oct; 52(4):. PubMed ID: 39129320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
    Int J Oncol; 2024 Nov; 65(5):. PubMed ID: 39329219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells.
    Chen YH; Zhou BY; Wu XJ; Xu JF; Zhang JA; Chen YH; Liang SS
    Oncol Rep; 2021 Feb; 45(2):786. PubMed ID: 33416180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corrigendum] miR‑27a promotes proliferation, migration, and invasion of colorectal cancer by targeting FAM172A and acts as a diagnostic and prognostic biomarker.
    Liu W; Qian K; Wei X; Deng H; Zhao B; Chen Q; Zhang J; Liu H
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corrigendum] SB‑T‑121205, a next‑generation taxane, enhances apoptosis and inhibits migration/invasion in MCF‑7/PTX cells.
    Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
    Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corrigendum] Deoxypodophyllotoxin inhibits cell viability and invasion by blocking the PI3K/Akt signaling pathway in human glioblastoma cells.
    Wang W; Gao W; Zhang L; Zhang D; Zhao Z; Bao Y
    Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36660948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Corrigendum] Altered expression of miR‑152 and miR‑148a in ovarian cancer is related to cell proliferation.
    Zhou X; Zhao F; Wang ZN; Song YX; Chang H; Chiang Y; Xu HM
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35169861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corrigendum] MicroRNA‑122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.
    Xu Q; Zhang M; Tu J; Pang L; Cai W; Liu X
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corrigendum] microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
    Lai Y; Zhao L; Hu J; Quan J; Chen P; Xu J; Guan X; Lai Y; Ni L
    Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38362959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Corrigendum] Beneficial effects of sulfonamide‑based gallates on osteoblasts
    Huang L; Jin P; Lin X; Lin C; Zheng L; Zhao J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
    Ji J; Shen I; Li Y; Liu Y; Shang Z; Niu Y
    Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway.
    Jin F; Wang H; Li D; Fang C; Li W; Shi Q; Diao Y; Ding Z; Dai X; Tao L; Sunagawa M; Wu F; Qian Y; Liu Y
    Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35147201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.
    Shu X; Liu H; Zhen R; Jie Y; Chen L; Qi H; Wang C; Wang R; Chen D; Ran Y
    Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37350398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corrigendum] RON and c‑Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells.
    Yin B; Liu Z; Wang Y; Wang X; Liu W; Yu P; Duan X; Liu C; Chen Y; Zhang Y; Pan X; Yao H; Liao Z; Tao Z
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.